{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T07:32:33Z","timestamp":1774942353854,"version":"3.50.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2013,5,3]],"date-time":"2013-05-03T00:00:00Z","timestamp":1367539200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s00253-013-4905-y","type":"journal-article","created":{"date-parts":[[2013,5,2]],"date-time":"2013-05-02T09:57:17Z","timestamp":1367488637000},"page":"4763-4773","source":"Crossref","is-referenced-by-count":25,"title":["Marine bacteria: potential sources for compounds to overcome antibiotic resistance"],"prefix":"10.1007","volume":"97","author":[{"given":"Sung-Hwan","family":"Eom","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Mog","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se-Kwon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,3]]},"reference":[{"key":"4905_CR1","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/S0031-9422(00)83773-5","volume":"19","author":"JRF Allen","year":"1980","unstructured":"Allen JRF, Holmstedt BR (1980) The simple \u03b2-carboline alkaloids. Phytochemistry 19:1573\u20131582","journal-title":"Phytochemistry"},{"key":"4905_CR2","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1128\/AAC.45.4.1058-1064.2001","volume":"45","author":"CM Apfel","year":"2001","unstructured":"Apfel CM, Locher H, Evers S, Takacs B, Hubschwerlen C, Pirson W, Page MGP, Keck W (2001) Peptide deformylase as an antibacterial drug target: target validation and resistance development. Antimicrob Agents Chemother 45:1058\u20131064","journal-title":"Antimicrob Agents Chemother"},{"key":"4905_CR3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S1359-6446(05)03667-6","volume":"11","author":"VL Arcus","year":"2006","unstructured":"Arcus VL, Lott JS, Johnston JM, Baker EN (2006) The potential impact of structural genomics on tuberculosis drug discovery. Drug Discov Today 11:28\u201334","journal-title":"Drug Discov Today"},{"key":"4905_CR4","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1021\/ol006942q","volume":"3","author":"T Barsby","year":"2001","unstructured":"Barsby T, Kelly MT, Gagne SM, Andersen RJ (2001) Bogorol A produced in culture by a marine Bacillus sp. reveals a novel template for cationic peptide antibiotics. Org Lett 3:437\u2013440","journal-title":"Org Lett"},{"key":"4905_CR5","doi-asserted-by":"crossref","first-page":"7792","DOI":"10.1021\/ja00311a111","volume":"107","author":"PA Bartlett","year":"1985","unstructured":"Bartlett PA, Johnson CR (1985) An inhibitor of chorismate mutase resembling the transition state conformation. J Am Chem Soc 107:7792\u20137793","journal-title":"J Am Chem Soc"},{"key":"4905_CR6","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.addr.2005.04.006","volume":"57","author":"MT Black","year":"2005","unstructured":"Black MT, Hodgson J (2005) Novel target sites in bacteria for overcoming antibiotic resistance. Adv Drug Deliv Rev 57:1528\u20131538","journal-title":"Adv Drug Deliv Rev"},{"key":"4905_CR7","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1177\/153537020623100402","volume":"231","author":"J Borysowski","year":"2006","unstructured":"Borysowski J, Weber-Dabrowska B, Gorski A (2006) Bacteriophage endolysins as a novel class of antibacterial agents. Exp Biol Med 231:366\u2013377","journal-title":"Exp Biol Med"},{"key":"4905_CR8","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1128\/AAC.44.2.272-277.2000","volume":"44","author":"S Boyle-Vavra","year":"2000","unstructured":"Boyle-Vavra S, Berke SK, Lee JC, Daum RS (2000) Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates. Antimicrob Agents Chemother 44:272\u2013277","journal-title":"Antimicrob Agents Chemother"},{"key":"4905_CR9","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3201\/eid0702.010204","volume":"7","author":"HF Chambers","year":"2001","unstructured":"Chambers HF (2001) The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis 7:178\u2013182","journal-title":"Emerg Infect Dis"},{"key":"4905_CR10","first-page":"239","volume":"1","author":"JM Clements","year":"2002","unstructured":"Clements JM, Ayscough A, Keavey K, East SP (2002) Peptide deformylase inhibitors, potential for a new class of broad spectrum antibacterials. Curr Med Chem 1:239\u2013249","journal-title":"Curr Med Chem"},{"key":"4905_CR11","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1021\/np0102713","volume":"64","author":"M Cueto","year":"2001","unstructured":"Cueto M, Jensen PR, Kauffman C, Fenical W, Lobkovsky E, Clardy J (2001) Pestalone, a new antibiotic produced by a marine fungus in response to bacterial challenge. J Nat Prod 64:1444\u20131446","journal-title":"J Nat Prod"},{"key":"4905_CR12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2672.2004.02422.x","volume":"98","author":"K Dabrowska","year":"2005","unstructured":"Dabrowska K, Switala-Jelen K, Opolski A, Weber-Dabrowska B, Gorski A (2005) Bacteriophage penetration in vertebrates. J Appl Microbiol 98:7\u201313","journal-title":"J Appl Microbiol"},{"key":"4905_CR13","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1021\/np300387n","volume":"75","author":"L Ding","year":"2012","unstructured":"Ding L, Maier A, Fiebig HH, Lin WH, Peschel G, Hertweck C (2012) Kandenols A-E, eudesmenes from an endophytic Streptomyces sp. of the mangrove tree Kandelia candel. J Nat Prod 75:2223\u20132227","journal-title":"J Nat Prod"},{"key":"4905_CR14","first-page":"251","volume":"14","author":"SH Eom","year":"2011","unstructured":"Eom SH, Park JH, Yu DU, Choi JI, Choi JD, Lee MS, Kim YM (2011) Antimicrobial activity of brown alga Eisenia bicyclis against methicillin-resistant Staphylococcus aureus. Fish Aquat Sci 14:251\u2013256","journal-title":"Fish Aquat Sci"},{"key":"4905_CR15","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1021\/cr00021a001","volume":"93","author":"W Fenical","year":"1993","unstructured":"Fenical W (1993) Chemical studies of marine bacteria: developing a new resource. Chem Rev 93:1673\u20131683","journal-title":"Chem Rev"},{"key":"4905_CR16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/clinids\/1.1.4","volume":"1","author":"M Finland","year":"1979","unstructured":"Finland M (1979) Emergence of antibiotic resistance in hospital 1935\u20131975. Rev Infect Dis 1:4\u201321","journal-title":"Rev Infect Dis"},{"key":"4905_CR17","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/nbt1206-1508","volume":"24","author":"VA Fischetti","year":"2006","unstructured":"Fischetti VA, Nelson D, Schuch R (2006) Reinventing phage therapy: are the parts greater than the sum? Nat Biotechnol 24:1508\u20131511","journal-title":"Nat Biotechnol"},{"key":"4905_CR18","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1371\/journal.pgen.0020007","volume":"2","author":"PE Fournier","year":"2006","unstructured":"Fournier PE, Vallenet D, Barbe V, Audic S, Ogata H, Poirel L, Richet H, Robert C, Mangenot S, Abergel C, Nordmann P, Weissenbach J, Raoult D, Claverie JM (2006) Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet 2:e7","journal-title":"PLoS Genet"},{"key":"4905_CR19","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1359-6446(05)03474-4","volume":"10","author":"C Freiberg","year":"2005","unstructured":"Freiberg C, Brotz-Oesterhelt H (2005) Functional genomics in antibacterial drug discovery. Drug Discov Today 10:927\u2013935","journal-title":"Drug Discov Today"},{"key":"4905_CR20","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1021\/np200597m","volume":"74","author":"P Fu","year":"2011","unstructured":"Fu P, Liu P, Qu H, Wang Y, Chen D, Wang H, Li J, Zhu W (2011) \u03b1-Pyrones and diketopiperazine derivatives from the marine-derived actinomycete Nocardiopsis dassonvillei HR10-5. J Nat Prod 74:2219\u20132223","journal-title":"J Nat Prod"},{"key":"4905_CR21","doi-asserted-by":"crossref","first-page":"873","DOI":"10.7164\/antibiotics.55.873","volume":"55","author":"T Furumai","year":"2002","unstructured":"Furumai T, Eto K, Sasaki T, Higuchi H, Onaka H, Saito N, Fujita T, Naoki H, Igarashi Y (2002) TPU-0037-A, B, C and D, novel lydicamycin congeners with anti-MRSA activity from Streptomyces platensis TP-A0598. J Antibiot 55:873\u2013880","journal-title":"J Antibiot"},{"key":"4905_CR22","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1021\/np980219f","volume":"62","author":"JM Gerard","year":"1999","unstructured":"Gerard JM, Haden P, Kelly MT, Andersen RJ (1999) Loloatins A\u2013D, cyclic decapeptide antibiotics produced in culture by a tropical marine bacterium. J Nat Prod 62:80\u201385","journal-title":"J Nat Prod"},{"key":"4905_CR23","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.coph.2005.06.002","volume":"5","author":"B Guignard","year":"2005","unstructured":"Guignard B, Entenza JM, Moreillon P (2005) Beta-lactams against methicillin-resistant Staphylococcus aureus. Curr Opin Pharmacol 5:479\u2013489","journal-title":"Curr Opin Pharmacol"},{"key":"4905_CR24","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1128\/jb.170.3.1360-1368.1988","volume":"170","author":"A Haese","year":"1988","unstructured":"Haese A, Keller U (1988) Genetics of actinomycin C production in Streptomyces chrysomallus. J Bacteriol 170:1360\u20131368","journal-title":"J Bacteriol"},{"key":"4905_CR25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nrd2223","volume":"6","author":"REW Hancock","year":"2007","unstructured":"Hancock REW (2007) The end of an era? Nat Rev Drug Discov 6:28","journal-title":"Nat Rev Drug Discov"},{"key":"4905_CR26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10156-006-0502-7","volume":"13","author":"Y Hososaka","year":"2007","unstructured":"Hososaka Y, Hanaki H, Endo H, Suzuki Y, Nagasawa Z, Otsuka Y, Nakae T, Sunakawa K (2007) Characterization of oxacillin-susceptible mecA positive Staphylococcus aureus: a new type of MRSA. J Infect Chemother 13:79\u201386","journal-title":"J Infect Chemother"},{"key":"4905_CR27","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1021\/ol702952n","volume":"10","author":"CC Hughes","year":"2008","unstructured":"Hughes CC, Prieto-Davo A, Jensen PR, Fenical W (2008) The marinopyrroles, antibiotics of an unprecedented structure class from a marine Streptomyces sp. Org Lett 10:629\u2013631","journal-title":"Org Lett"},{"key":"4905_CR28","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/oxfordjournals.jac.a002694","volume":"47","author":"A Isnansetyo","year":"2001","unstructured":"Isnansetyo A, Horikawa M, Kamei Y (2001) In vitro anti-methicillin resistant Staphylococcus aureus activity of 2,4-diacetylphloroglucinol produced by a Pseudomonas sp AMSN isolated from a marine alga. J Antimicrob Chemother 47:724\u2013725","journal-title":"J Antimicrob Chemother"},{"key":"4905_CR29","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1128\/AAC.47.2.480-488.2003","volume":"47","author":"A Isnansetyo","year":"2003","unstructured":"Isnansetyo A, Kamei Y (2003) MC21-A, a bactericidal antibiotic produced by a new marine bacterium, Pseudoalteromonas phenolica sp. nov. O-BC30T, against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 47:480\u2013488","journal-title":"Antimicrob Agents Chemother"},{"key":"4905_CR30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijantimicag.2009.02.009","volume":"34","author":"A Isnansetyo","year":"2009","unstructured":"Isnansetyo A, Kamei Y (2009) Anti-methicillin-resistant Staphylococcus aureus (MRSA) activity of MC21-B, an antibacterial compound produced by the marine bacterium Pseudoalteromonas phenolica O-B30T. Int J Antimicrob Agents 34:131\u2013135","journal-title":"Int J Antimicrob Agents"},{"key":"4905_CR31","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1128\/AAC.45.5.1323-1336.2001","volume":"45","author":"T Ito","year":"2001","unstructured":"Ito T, Katayama Y, Asada K, Mori N, Tsutsumimoto K, Tiensasitorn C, Hiramatsu K (2001) Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 45:1323\u20131336","journal-title":"Antimicrob Agents Chemother"},{"key":"4905_CR32","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/bmj.1.5219.124-a","volume":"1","author":"MP Jevons","year":"1961","unstructured":"Jevons MP (1961) Celbenin-resistant staphylococci. Br Med J 1:124\u2013125","journal-title":"Br Med J"},{"key":"4905_CR33","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/ja.2008.29","volume":"61","author":"K Kanoh","year":"2008","unstructured":"Kanoh K, Adachi K, Matsuda S, Shizuri Y, Yasumoto K, Kusumi T, Okumura K, Kirikae T (2008) New sulfoalkylresorcinol from marine-derived fungus, Zygosporium sp. KNC52. J Antibiot 61:192\u2013194","journal-title":"J Antibiot"},{"key":"4905_CR34","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1128\/JCM.43.5.2380-2383.2005","volume":"43","author":"Y Katayama","year":"2005","unstructured":"Katayama Y, Robinson DA, Enright MC, Chambers HF (2005) Genetic background affects stability of mecA in Staphylococcus aureus. J Clin Microbiol 43:2380\u20132383","journal-title":"J Clin Microbiol"},{"key":"4905_CR35","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1016\/j.bmc.2009.02.050","volume":"17","author":"K Kaur","year":"2009","unstructured":"Kaur K, Jain M, Kaur T, Jain R (2009) Antimalarials from nature. Bioorg Med Chem 17:3229\u20133256","journal-title":"Bioorg Med Chem"},{"key":"4905_CR36","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.3201\/eid1312.070629","volume":"13","author":"E Klein","year":"2007","unstructured":"Klein E, Smith DL, Laxminarayan R (2007) Hospitalizations and Deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999\u20132005. Emerg Infect Dis 13:1840\u20131846","journal-title":"Emerg Infect Dis"},{"key":"4905_CR37","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1001\/jama.298.15.1763","volume":"298","author":"RM Klevens","year":"2007","unstructured":"Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK (2007) Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298:1763\u20131771","journal-title":"JAMA"},{"key":"4905_CR38","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1128\/CMR.10.3.505","volume":"10","author":"J Kluytmans","year":"1997","unstructured":"Kluytmans J, van Belkum A, Verbrugh H (1997) Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 10:505\u2013520","journal-title":"Clin Microbiol Rev"},{"key":"4905_CR39","unstructured":"Lee DS (2009) Isolation and characterization of anti-MRSA (methicillin-resistant Staphylococcus aureus) substances from marine organisms. Ph.D. dissertation, Department of Microbiology, Pukyong National University, Busan. Chapter 1, pp. 2\u201323."},{"key":"4905_CR40","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s12257-008-0162-9","volume":"13","author":"DS Lee","year":"2008","unstructured":"Lee DS, Kang MS, Hwang HJ, Eom SH, Yang JY, Lee MS, Lee WJ, Jeon YJ, Choi JS, Kim YM (2008) Synergistic effect between dieckol from Ecklonia stolonifera and \u03b2-lactams against methicillin-resistant Staphylococcus aureus. Biotechnol Bioprocess Eng 13:758\u2013764","journal-title":"Biotechnol Bioprocess Eng"},{"key":"4905_CR41","first-page":"1367","volume":"338","author":"SB Levy","year":"1998","unstructured":"Levy SB (1998) Multidrug resistance\u2014a sign of the times. N Engl J Med 338:1367\u20131368","journal-title":"N Engl J Med"},{"key":"4905_CR42","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.addr.2005.04.001","volume":"57","author":"SB Levy","year":"2005","unstructured":"Levy SB (2005) Antibiotic resistance\u2014the problem intensifies. Adv Drug Deliv Rev 57:1446\u20131450","journal-title":"Adv Drug Deliv Rev"},{"key":"4905_CR43","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3390\/md9081428","volume":"9","author":"S Li","year":"2011","unstructured":"Li S, Tian X, Niu S, Zhang W, Chen Y, Zhang H, Yang X, Zang W, Li W, Zamg S, Ju J, Zhang C (2011) Pseudonocardians A\u2013C, new diazaanthraquinone derivatives from a deep-sea actinomycete Pseudonocardia sp. SCSIO 01299. Mar Drugs 9:1428\u20131439","journal-title":"Mar Drugs"},{"key":"4905_CR44","first-page":"516","volume":"38","author":"Y Lim","year":"1995","unstructured":"Lim Y, Chang JH, Kim JH, Shu JW, Jung JK, Lee CH (1995) Structure elucidation of a potent anti-MRSA antibiotic AM3, produced by Streptomyces sp. Agric Chem Biotechnol 38:516\u2013521","journal-title":"Agric Chem Biotechnol"},{"key":"4905_CR45","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S1359-6446(98)01238-0","volume":"3","author":"AW Lloyd","year":"1998","unstructured":"Lloyd AW (1998) Monitor: molecules and profiles. Drug Discov Today 3:480\u2013482","journal-title":"Drug Discov Today"},{"key":"4905_CR46","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJM199808203390806","volume":"339","author":"FD Lowy","year":"1998","unstructured":"Lowy FD (1998) Staphylococcus aureus infections. N Engl J Med 339:520\u2013532","journal-title":"N Engl J Med"},{"key":"4905_CR47","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1021\/np9001477","volume":"72","author":"TA Mansoor","year":"2009","unstructured":"Mansoor TA, Ramalhete C, Molnar J, Mulhovo S, Ferreira MJU (2009) Tabernines A\u2013C, \u03b2-carbolines from the leaves of Tabernaemontana elegans. J Nat Prod 72:1147\u20131150","journal-title":"J Nat Prod"},{"key":"4905_CR48","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1128\/AAC.44.7.1825-1831.2000","volume":"44","author":"PS Margolis","year":"2000","unstructured":"Margolis PS, Hackbarth CJ, Young DC, Wang W, Chen D, Yuan Z, White R, Trias J (2000) Peptide deformylase in Staphylococcus aureus: resistance to inhibition is mediated by mutations in the formyltransferase gene. Antimicrob Agents Chemother 44:1825\u20131831","journal-title":"Antimicrob Agents Chemother"},{"key":"4905_CR49","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.surg.2005.02.012","volume":"137","author":"T Matsuda","year":"2005","unstructured":"Matsuda T, Freeman TA, Hilbert DW, Duff M, Fuortes M, Stapleton PP, Daly JM (2005) Lysis-deficient bacteriophage therapy decreases endotoxin and inflammatory mediator release and improves survival in a murine peritonitis model. Surgery 137:639\u2013646","journal-title":"Surgery"},{"key":"4905_CR50","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1021\/np800286d","volume":"71","author":"KA McArthur","year":"2008","unstructured":"McArthur KA, Mitchell SS, Tsueng G, Rheingold A, White DJ, Grodberg J, Lam KS, Potts BCM (2008) Lynamicins A\u2013E, chlorinated bisindole pyrrole antibiotics from a novel marine actinomycete. J Nat Prod 71:1732\u20131737","journal-title":"J Nat Prod"},{"key":"4905_CR51","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s10295-008-0344-7","volume":"35","author":"S Michelle","year":"2008","unstructured":"Michelle S, Teisan S, Tsueng G, Venkat M, Kin L (2008) Seawater requirement for the production of lipoxazolidinones by marine actinomycete strain NPS8920. J Ind Microb Biotech 35:761\u2013765","journal-title":"J Ind Microb Biotech"},{"key":"4905_CR52","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.bcp.2005.11.025","volume":"71","author":"SD Mills","year":"2006","unstructured":"Mills SD (2006) When will the genomics investment pay off for antibacterial discovery? Biochem Pharmacol 71:1096\u20131102","journal-title":"Biochem Pharmacol"},{"key":"4905_CR53","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.bcp.2005.11.023","volume":"71","author":"RL Monaghan","year":"2006","unstructured":"Monaghan RL, Barrett JF (2006) Antibacterial drug discovery\u2014then, now and the genomics future. Biochem Pharmacol 71:901\u2013909","journal-title":"Biochem Pharmacol"},{"issue":"12","key":"4905_CR54","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1021\/np200487k","volume":"74","author":"MM Mondol","year":"2011","unstructured":"Mondol MM, Tareq FS, Kim JH, Lee MA, Lee HS, Lee YJ, Lee JS, Shin HJ (2011) Cyclic ether-containing macrolactins, antimicrobial 24-membered isomeric macrolactones from a marine Bacillus sp. J Nat Prod 74(12):2582\u20132587","journal-title":"J Nat Prod"},{"key":"4905_CR55","first-page":"247","volume":"31","author":"GGF Nascimento","year":"2000","unstructured":"Nascimento GGF, Locatelli J, Freitas PC, Silva GL (2000) Antibacterial activity of plant extracts and phytochemicals on antibiotic-resistant bacteria. Braz J Microbiol 31:247\u2013256","journal-title":"Braz J Microbiol"},{"key":"4905_CR56","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1021\/jo00087a020","volume":"59","author":"J Needham","year":"1994","unstructured":"Needham J, Kelly MT, Ishige M, Andersen RJ (1994) Andrimid and moiramides A\u2013C, metabolites produced in culture by a marine isolate of the bacterium Pseudomonas fluorescens: structure elucidation and biosynthesis. J Org Chem 59:2058\u20132063","journal-title":"J Org Chem"},{"key":"4905_CR57","first-page":"447","volume":"45","author":"JY Park","year":"2007","unstructured":"Park JY, Jin JS, Kang HY, Jeong EH, Lee JC, Lee YC, Seol SY, Cho DT, Kim J (2007) A comparison of adult and pediatric methicillin-resistant Staphylococcus aureus isolates collected from patients at a university hospital in Korea. J Microbiol 45:447\u2013452","journal-title":"J Microbiol"},{"key":"4905_CR58","first-page":"337","volume":"10","author":"B Proksa","year":"1990","unstructured":"Proksa B, Uhrin D, Sturdikova M, Fuska J (1990) 1-Acetyl-\u03b2-carboline, a new metabolite of Streptomyces kasugaensis. Scta Biotechnol 10:337\u2013340","journal-title":"Scta Biotechnol"},{"key":"4905_CR59","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7164\/antibiotics.57.271","volume":"57","author":"J Riedlinger","year":"2004","unstructured":"Riedlinger J, Reicke A, Z\u00e4hner H, Krismer B, Bull AT, Maldonado LA, Ward AC, Goodfellow M, Bister B, Bischoff D, S\u00fcssmuth RD, Fiedler HP (2004) Abyssomicins, inhibitors of the para-aminobenzoic acid pathway produced by the marine Verrucosispora strain AB-18-032. J Antibiot 57:271\u2013279","journal-title":"J Antibiot"},{"key":"4905_CR60","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3233\/ISB-00138","volume":"4","author":"KR Sakharkar","year":"2004","unstructured":"Sakharkar KR, Sakharkar MK, Chow VT (2004) A novel genomics approach for the identification of drug targets in pathogens, with special reference to Pseudomonas aeruginosa. In Silico Biol 4:355\u2013360","journal-title":"In Silico Biol"},{"key":"4905_CR61","doi-asserted-by":"crossref","first-page":"72S","DOI":"10.1016\/0002-9343(91)90346-Y","volume":"91","author":"DR Schaberg","year":"1991","unstructured":"Schaberg DR, Culver DH, Gaynes RP (1991) Major trends in the microbial etiology of nosocomial infection. Am J Med 91:72S\u201375S","journal-title":"Am J Med"},{"key":"4905_CR62","first-page":"501","volume":"20","author":"HJ Shin","year":"2010","unstructured":"Shin HJ, Lee HS, Lee DS (2010) The synergistic antibacterial activity of 1-acetyl-\u03b2-carboline and \u03b2-lactams against methicillin-resistant Staphylococcus aureus (MRSA). J Microbiol Biotechnol 20:501\u2013505","journal-title":"J Microbiol Biotechnol"},{"key":"4905_CR63","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1348-0421.2004.tb03489.x","volume":"48","author":"S Shiota","year":"2004","unstructured":"Shiota S, Shimizu M, Sugiyama J, Morita Y, Mizushima T, Tsuchiya T (2004) Mechanisms of action of corilagin and tellimagrandin I that remarkably potentiate the activity of \u03b2-lactams against methicillin-resistant Staphylococcus aureus. Microbiol Immunol 48:67\u201373","journal-title":"Microbiol Immunol"},{"key":"4905_CR64","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.7164\/antibiotics.46.1834","volume":"46","author":"H Shiozawa","year":"1993","unstructured":"Shiozawa H, Kagasaki T, Kinoshita T, Haruyama H, Domon H, Utsui Y, Kodama K, Takahashi S (1993) Thiomarinol, a hybrid antimicrobial antibiotic produced by a marine bacterium fermentation, isolation, structure and antimicrobial activity. J Antibiot 46:1834\u20131842","journal-title":"J Antibiot"},{"key":"4905_CR65","doi-asserted-by":"crossref","first-page":"907","DOI":"10.7164\/antibiotics.48.907","volume":"48","author":"H Shiozawa","year":"1995","unstructured":"Shiozawa H, Kagasaki T, Torikata A, Tanaka N, Fujimoto K, Hata T, Furukawa Y, Takahashi S (1995) Thiomarinol B, thiomarinol C, new antimicrobial antibiotics produced by a marine bacterium. J Antibiot 48:907\u2013909","journal-title":"J Antibiot"},{"key":"4905_CR66","doi-asserted-by":"crossref","first-page":"449","DOI":"10.7164\/antibiotics.50.449","volume":"50","author":"H Shiozawa","year":"1997","unstructured":"Shiozawa H, Shimada A, Takahashi S (1997) Thiomarinols D, E, F and G, new hybrid antimicrobial antibiotics produced by a marine bacterium; isolation, structure, and antimicrobial activity. J Antibiot 50:449\u2013452","journal-title":"J Antibiot"},{"key":"4905_CR67","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.7164\/antibiotics.56.1033","volume":"56","author":"MP Singh","year":"2003","unstructured":"Singh MP, Kong F, Janso JE, Arias DA, Suarez PA, Bernan VS, Petersen PJ, Weiss WJ, Carter G, Greenstein M (2003) Novel alpha-pyrones produced by a marine Pseudomonas sp. F92S91: taxonomy and biological activities. J Antibiot 56:1033\u20131044","journal-title":"J Antibiot"},{"key":"4905_CR68","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1021\/np058011z","volume":"68","author":"IE Soria-Mercado","year":"2005","unstructured":"Soria-Mercado IE, Prieto-Davo A, Jensen PR, Fenical W (2005) Antibiotic terpenoid chloro-dihydroquinones from a new marine actinomycete. J Nat Prod 68:904\u2013910","journal-title":"J Nat Prod"},{"key":"4905_CR69","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1128\/AAC.45.3.649-659.2001","volume":"45","author":"A Sulakvelidze","year":"2001","unstructured":"Sulakvelidze A, Alavidze Z, Morris JG (2001) Bacteriophage therapy. Antimicrob Agents Chemother 45:649\u2013659","journal-title":"Antimicrob Agents Chemother"},{"key":"4905_CR70","doi-asserted-by":"crossref","first-page":"6557","DOI":"10.1016\/j.bmc.2011.06.053","volume":"19","author":"P Sun","year":"2011","unstructured":"Sun P, Maloney KN, Nam SJ, Haste NM, Raju R, Aalbersberg W, Jensen PR, Nizet V, Hensler ME, Fenical W (2011) Fijimycins A\u2013C, three antibacterial etamycin-class depsipeptides from a marine-derived Streptomyces sp. Bioorg Med Chem 19:6557\u20136562","journal-title":"Bioorg Med Chem"},{"key":"4905_CR71","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.diagmicrobio.2006.10.022","volume":"58","author":"JM Swenson","year":"2007","unstructured":"Swenson JM, Lonsway D, McAllister S, Thompson A, Jevitt L, Zhu W, Patel JB (2007) Detection of mecA-mediated resistance using reference and commercial testing methods in a collection of Staphylococcus aureus expressing borderline oxacillin MICs. Diagn Microbiol Infect Dis 58:33\u201339","journal-title":"Diagn Microbiol Infect Dis"},{"key":"4905_CR72","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1039\/b100918o","volume":"18","author":"RX Tan","year":"2001","unstructured":"Tan RX, Zou WX (2001) Endophytes: a rich source of functional metabolites. Nat Prod Rep 18:448\u2013459","journal-title":"Nat Prod Rep"},{"key":"4905_CR73","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1016\/j.bmcl.2007.05.070","volume":"17","author":"JI Trujillo","year":"2007","unstructured":"Trujillo JI, Meyers MJ, Anderson DR, Hegde S, Mahoney MW, Vernier WF, Buchler IP, Wu KK, Yang S, Hartmann SJ, Reitz DB (2007) Novel tetrahydro-\u03b2-carboline-1-carboxylic acids as inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2). Bioorg Med Chem Lett 17:4657\u20134663","journal-title":"Bioorg Med Chem Lett"},{"key":"4905_CR74","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/jac\/47.2.163","volume":"47","author":"P Vaudaux","year":"2001","unstructured":"Vaudaux P, Francois P, Berger-Bachi B, Lew DP (2001) In vivo emergence of subpopulations expressing teicoplanin or vancomycin resistance phenotypes in a glycopeptides-susceptible, methicillin-resistant strain of Staphylococcus aureus. J Antimicrob Chemother 47:163\u2013170","journal-title":"J Antimicrob Chemother"},{"key":"4905_CR75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/44.suppl_1.1","volume":"44","author":"W Witte","year":"1999","unstructured":"Witte W (1999) Antibiotic resistance in Gram-positive bacteria: epidemiological aspects. J Antimicrob Chemother 44:1\u20139","journal-title":"J Antimicrob Chemother"},{"key":"4905_CR76","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1469-0691.2006.01671.x","volume":"13","author":"W Witte","year":"2007","unstructured":"Witte W, Pasemann B, Cuny C (2007) Detection of low-level oxacillin resistance in mecA-positive Staphylococcus aureus. Clin Microbiol Infect 13:408\u2013412","journal-title":"Clin Microbiol Infect"},{"key":"4905_CR77","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1469-0691.2005.01140.x","volume":"11","author":"N Woodford","year":"2005","unstructured":"Woodford N (2005) Biological counterstrike: antibiotic resistance mechanisms of Gram-positive cocci. Clin Microbiol Infect 11:2\u201321","journal-title":"Clin Microbiol Infect"},{"key":"4905_CR78","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1351\/pac199971091655","volume":"71","author":"RN Young","year":"1999","unstructured":"Young RN (1999) Importance of biodiversity to the modern pharmaceutical industry. Pure Appl Chem 71:1655\u20131661","journal-title":"Pure Appl Chem"},{"key":"4905_CR79","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.bcp.2005.10.015","volume":"71","author":"Z Yuan","year":"2006","unstructured":"Yuan Z, White RJ (2006) The evolution of peptide deformylase as a target: contribution of biochemistry, genetics and genomics. Biochem Pharmacol 71:1042\u20131047","journal-title":"Biochem Pharmacol"},{"key":"4905_CR80","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1128\/AAC.45.6.1737-1742.2001","volume":"45","author":"WH Zhao","year":"2001","unstructured":"Zhao WH, Hu ZQ, Okubo S, Hara Y, Shimamura T (2001) Mechanism of synergy between epigallocatechin gallate and \u03b2-lactam antibiotics against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 45:1737\u20131742","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-013-4905-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00253-013-4905-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-013-4905-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T07:58:17Z","timestamp":1745999897000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00253-013-4905-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,3]]},"references-count":80,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["4905"],"URL":"https:\/\/doi.org\/10.1007\/s00253-013-4905-y","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"value":"0175-7598","type":"print"},{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,3]]}}}